Cite
HARVARD Citation
Kang, B. et al. (n.d.). DOP83 Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial. Journal of Crohn's and colitis. p. i159. [Online].